Practice patterns for the evaluation and treatment of eosinophilic oesophagitis

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 11-12, 2010, Pages 1373-1382

  Peery, A F ^a   Shaheen, N J ^a   Dellon, E S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PROTON PUMP INHIBITOR; STEROID;

ARTICLE; CLINICAL PRACTICE; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS PH; GASTROINTESTINAL ENDOSCOPY; HEALTH SURVEY; HUMAN; MEDICAL ASSESSMENT; MEDICAL SPECIALIST; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ADRENAL CORTEX HORMONES; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY HEALTH SERVICES; ESOPHAGITIS; GASTROENTEROLOGY; GUIDELINE ADHERENCE; HUMANS; INTERNET; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; QUESTIONNAIRES;

EID: 78449310339     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04476.x     Document Type: Article

References (24)

1. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342 - 63.
2. Noel RJ, Putnam PE, Rothenberg ME,. Eosinophilic esophagitis. N Engl J Med 2004; 351: 940 - 1.
3. Prasad GA, Alexander JA, Schleck CD, et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7: 1055 - 61.
4. Straumann A, Simon HU,. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005; 115: 418 - 9.
5. Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007; 56: 615 - 20.
6. Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 1305 - 13.
7. Gonsalves N, Kahrilas PJ,. Eosinophilic oesophagitis in adults. Neurogastroenterol Motil 2009; 21: 1017 - 26.
8. Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ,. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007; 102: 2300 - 13.
9. Elliott EJ, Thomas D, Markowitz JE,. Non-surgical interventions for eosinophilic esophagitis. Cochrane Database Syst Rev 2010; 3: CD004065.
10. Spechler SJ, Genta RM, Souza RF,. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007; 102: 1301 - 6.
11. Merwat SN, Spechler SJ,. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol 2009; 104: 1897 - 902.
12. Kedika RR, Souza RF, Spechler SJ,. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci 2009; 54: 2312 - 7.
13. Attwood SE, Smyrk TC, Demeester TR, Jones JB,. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109 - 16.
14. Dellon ES, Farrell TM, Bozymski EM, Shaheen NJ,. Diagnosis of eosinophilic esophagitis after fundoplication for refractory reflux: implications for preoperative evaluation. Dis Esophagus 2010; 23: 191 - 5.
15. Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381 - 91.
16. Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 2008; 6: 165 - 73.
17. Dohil R, Newbury R, Fox L, Bastian J, Aceves S,. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418 - 29.
18. Straumann A, Degen L, Felder S, et al. Budesonide as induction treatment for active eosinophilic esophagitis in adolescents and adults: a randomized, double-blind, placebo-controlled study (Bee-I trial). Gastroenterology 2008; 134 (Suppl. 1): A104.
19. Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010 [Epub ahead of print].
20. Zhang X, Cheng E, Huo X, Hormi-Carver K, Andersen J, Spechler S, et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin-3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology 2010; 138 (Suppl. 1): S122 [Abstract 877].
21. King J, Khan S,. Eosinophilic esophagitis: perspectives of adult and pediatric gastroenterologists. Dig Dis Sci 2010; 55: 973 - 82.
22. Spiegel BM, Farid M, Esrailian E, Talley J, Chang L,. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848 - 58.
23. Spiegel BM, Farid M, Van Oijen MG, Laine L, Howden CW, Esrailian E,. Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther 2009; 29: 871 - 81.
24. Adler DG, Hilden K, Wills JC, Quinney E, Fang JC,. What drives US gastroenterology fellows to pursue academic vs. non-academic careers?: results of a national survey. Am J Gastroenterol 2010; 105: 1220 - 3.